CytomX Therapeutics, Inc. (CTMX)
3.76
+0.04
(+1.08%)
USD |
NASDAQ |
May 21, 16:00
3.75
-0.01
(-0.27%)
After-Hours: 19:59
CytomX Therapeutics Research and Development Expense (TTM) : 68.10M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| Rigel Pharmaceuticals, Inc. | 36.54M |
| Ovid Therapeutics, Inc. | 29.96M |
| Gossamer Bio, Inc. | 179.10M |
| Mirum Pharmaceuticals, Inc. | 237.68M |